Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
73 /100
HIGH RISK
Score updated Aug 28, 2026

PSTV — Plus Therapeutics, Inc. Dilution Risk Tracker

Track PSTV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PSTV — Get alerts when the score changes →

As of August 28, 2026, Plus Therapeutics, Inc. (PSTV) has a DilutionWatch DilutionScore of 73/100, rated HIGH dilution risk. Plus Therapeutics, Inc. has a market capitalization of $40.06M, 7.59M shares outstanding, 24 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $15.00B.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
85
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 30%
💰 Capital Raise model 55%
• Low cash runway: 4 months remaining
• Active shelf registration ($15000M, 37444% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (73/100)
🔔 Track PSTV — Get forecast alerts →

Market Data

Market Cap$40.06M
Shares Outstanding7.59M
Float6.46M
Cash$8.59M
Debt$7.38M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 0.1% shares (2026Q1 vs prior)
24 institutional holders · 11.56M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 4.85M shares
#2 GEODE CAPITAL MANAGEMENT, LLC 2.02M shares
#3 BlackRock, Inc. 1.78M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest631.0K
Days to Cover7.8
% of Float9.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2015-12-31
4 INSIDER TRANSACTION 2026-04-01
4 INSIDER TRANSACTION 2026-04-01
3 FORM3 2026-03-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PSTV Dilution Snapshot

Plus Therapeutics, Inc. (PSTV) has a DilutionScore of 73/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PSTV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PSTV — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PSTV
PSTV FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.